Advisory Board and Editors Synthetic Biology

Edward A. Bayer

Professor, Wishner Chair of Bio-organic Chemistry. Early development of avidin-biotin technology. Co-discoverer of the cellulosome concept. Editor/Editoral Board: Biotechnology Advances, Biotechnology for Biofuels, Current Opinion in Biotechnology, Industrial Biotechnology. Member of Scientific Advisory Board, US-DOE BioEnergy Science Center (BESC). Sarstedt Research Award, The Ulitzky Prize, Fellowship of the American Academy of Microbiology and European Academy of Microgiology.

Kerstin Blank

Max Planck Research Group Leader since 2014; assistant professor at Radboud University Nijmegen; PostDocs at University of Leuven and University of Strasbourg; PhD in Biophysics from Ludwig Maximilian University Munich; Research interests: mechanobiology, molecular force sensors, protein engineering, single molecule techniques (force and fluorescence); Editor of Biophysical Reviews and Letters

Bettina Böttcher

Professor for Biochemistry with Focus on electron Cryo Microscopy at the Julius Maximilians University Würzburg

Guo-Qiang Chen

Professor, School of Life Sciences, Tsinghua University, Beijing. Over 23 issued patents and 30 pending patents.

Albert Cheng

Albert Cheng obtained his BSc in Biochemistry and MPhil in Biology from Hong Kong University of Science and Technology in 2005 and 2007, respectively. He studied neurotrophin signaling and C. elegans developmental genetics. He then pursued his PhD in Computational & Systems Biology at MIT in the labs of Profs Christopher Burge and Rudolf Jaenisch and worked on various topics on epigenetics, gene regulation and alternative splicing in stem cells, reprogramming, cancer metastasis, erythropoiesis and differentiation. Cheng and colleagues identified H3K27ac as a signature for active enhancers. He analyzed alternative splicing in epithetlial-mesenchymal transition, cancer metastasis as well as erythropoiesis and identified splicing factors regulating these processes. He constructed CRISPR-on, an artificial RNA-guided activator based on CRISPR/Cas. After graduating in 2014, he joined the Jackson Laboratory at Bar Harbor, ME, as one of the first JAX scholars where he continued to work on understanding and improving the CRISPR/Cas technology. In July 2015, he started his own lab as an assistant professor at the Jackson Laboratory for Genomic Medicine campus at Farmington, CT.

Dick de Ridder

Dick de Ridder heads the Bioinformatics Group at Wageningen University. His group develops novel computational methods to analyze, interpret and model –omics data, in particular genomics and transcriptomics, and collaborates intensively with various key research groups in the green life sciences

Rumiana Dimova

Group leader at the Max Planck Institute of Colloids and Interfaces since 2005
PhD in Biophysics from Bordeaux University
Awarded the Emmy Noether Distinction for Women in Physics in 2014
Research interests: mechanical, rheological and electrical properties of membranes, colloidal interactions, molecular crowding

Drew Endy

Faculty of Bioengineering, Stanford University. Helped start BioBricks (biobricks.org) and iGEM (igem.org), and is a member of the US National Advisory Board for Biosecurity (biosecurityboard.gov).

Mark C Enright

2015 – date Professor of Medical Microbiology, School of Healthcare Sciences, Manchester Metropolitan University, UK
2013 – 2015 Consultant and Lead advisor to Synthetic Genomics Vaccine Inc. La Jolla, CA. USA
2011 – 2014 Visiting Professor, University of Bath, UK
2010 – 2012 Research Director, AmpliPhi Biosciences Corporation, Sharnbrook, UK and Virginia BioTechnology Research Park, Richmond, USA
2008 – 2010 Director, Intelligent Fabric Technologies PLC
2005 – 2010 Reader then Professor, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, UK
2000 – 2005 Reader / Senior research fellow, University of Bath, UK
1997 - 2000 Postdoctoral research fellow - University of Oxford, UK

Mario Alberto Flores-Valdez

Dr. Mario Alberto Flores-Valdez is a Professor in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., Guadalajara, Jalisco, Mexico (2007-present). He is a member of the National System of Researchers (SNI), he was a Stanford University Medical Center postdoctoral fellow (2004-2007), where he received a Dean's Fellowship Award (2006) to conduct research on Tuberculosis. He worked in UNAM as Research Assistant for Prof. Jaime Mora (2004) and Prof. Emundo Calva (2003). He has received a Ph.D. in Biochemistry from UNAM (1999-2003), a M.Sc. in Molecular Biology and Genetic Engineering from UANL (1996-1999) and a B.Sc. from Universidad de Sonora (1991-1996) in Chemistry and Biology. He has received fellowships from CONACYT for M.Sc. and Ph.D. studies and in M.Sc. and B.Sc. has received Diplomas as Best Student. He has reviewed articles for several peer-reviewed journal and has expertise in Tuberculosis, particularly in developing recombinant BCG strains. He has been PI for 6 grants from 2008 to date, focused in studies about tuberculosis vaccine development and basic aspects of mycobacterial physiology.

Pietro Gatti-Lafranconi

Biotechnologist by training, Pietro spent many years in Academia working on the understanding of the structural and functional determinants of molecular evolution processes in enzymes, protein binders and transcription Factors. Now applies these strategies in a Company's R&D department.